Slide 1Evidence-Based Management of Anticoagulant Therapy ----- Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-…

Slide 1Low Molecular Weight Heparin as bridging anticoagulant early after mechanical heart valve replacement. P Meurin, JY Tabet, A Ben Driss, H Weber, N Renaud Les Grands…

Slide 1A Multi-Laboratory Evaluation of a Chromogenic Factor X Assay for Monitoring Oral Anticoagulation Therapy DL McGlasson 1*; PN Shaklee 2; 1 59 th Clinical Research…

Slide 1Mind the Gap: AF and the Evolving Strategies in Anticoagulation In Cooperation with Slide 2 Faculty Disclosures Fred M. Kusomoto, MD, FACC Mayo Clinic Consulting Fees/Honoraria:…

1. Primary Care Clinical Research & Trials Unit Prof Richard Lilford Outgoing Director PC-CRTU 2. What makes a great Primary Care Trial? Clever & Imaginative CliniciansTrials…

1. Professor Bernhard Meier, Department of Cardiology, University Hospital Bern, 3010 Bern, Switzerland; [email protected] 2. A patent foramen ovale (PFO) is present…

1. ≈15-20% of all strokes due to AF ≈90% of AF strokes cardioembolic ≈90% of emboli forms In the LAA 2. Parekh A et al. Circulation. 2006;114:e513-e514 3. Yamaji, et…

1. Primary Care Clinical Research & Trials Unit Prof Richard Lilford Outgoing Director PC-CRTU 2. What makes a great Primary Care Trial? Clever & Imaginative CliniciansTrials…

REVIEW Clinical update Pulmonary embolism: risk assessment and management Stavros Konstantinides1,2* and Samuel Z. Goldhaber3 1Center for Thrombosis and Hemostasis, Johannes…

Slide 1 LAA Closure Devices: Protecting Against Stroke Moderator Ted E. Feldman, MD Director Cardiac Catheterization Laboratory Evanston Hospital Evanston, Illinois Slide…